Healthcare stocks jump after Republicans unveil plan; banks, staples slip
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Accenture plc (ACN) PT Raised to $130 at BMO Capital on 3Q Report; 'Story & Opportunity Remain Fairly Steady'
June 23, 2017 9:26 AM EDTBMO Capital raised its price target on Accenture plc (NYSE: ACN) to $130.00 (from $125.00) while maintaining a Market Perform rating, following the company's third quarter earnings report.
Analyst Keith Bachman notes the company delivered in-line third quarter earnings per share results, while offering revenues above... More
Oracle (ORCL) PT Raised to $56 at Canaccord Genuity on 4Q Beat; 'Expects PaaS & IaaS Business to Enter Hyper-Growth in F18'
June 22, 2017 10:58 AM EDTCanaccord Genuity raised its price target on Oracle (NYSE: ORCL) to $56.00 (from $49.00) while maintaining a Buy rating, following the company's fourth quarter earnings announcement.
Analyst Richard Davis notes the company delivered fourth quarter earnings per share, revenues and margins above consensus projections... More
Oracle (ORCL) PT Raised to $52 at UBS Following 4Q
June 22, 2017 9:18 AM EDTUBS raised its price target on Oracle (NYSE: ORCL) to $52.00 (from $48.00) while maintaining a Buy rating following the company's 4Q earnings report.
The standout highlights from ORCL's 4Q was the $500M revenue beat and +200bps of margin upside, which combined delivered ~7c of EPS outperformance.
... MoreOracle (ORCL) PT Raised to $57 at BMO Capital on 4Q Beat; 'Strong Performance was Broadly Based'
June 22, 2017 8:58 AM EDTBMO Capital raised its price target on Oracle (NYSE: ORCL) to $57.00 (from $48.00) while maintaining a Outperform rating, following the company's fourth quarter announcement.
Analyst Keith Bachman notes the company delivered fourth quarter earnings per share, revenues and operating margins above consensus projections... More
Oracle (ORCL) PT Raised to $48 at Deutsche Bank Following 4Q
June 22, 2017 7:39 AM EDTDeutsche Bank raised its price target on Oracle (NYSE: ORCL) to $48.00 (from $44.00) while maintaining a Hold rating.... More



